IMPA2 Antikörper (AA 4-242)
-
- Target Alle IMPA2 Antikörper anzeigen
- IMPA2 (Inositol(myo)-1(or 4)-Monophosphatase 2 (IMPA2))
-
Bindungsspezifität
- AA 4-242
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IMPA2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Purified by antigen-affinity chromatography.
- Immunogen
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 4 and 242 of Human IMPA2
- Top Product
- Discover our top product IMPA2 Primärantikörper
-
-
- Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
- Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
- Target
- IMPA2 (Inositol(myo)-1(or 4)-Monophosphatase 2 (IMPA2))
- Andere Bezeichnung
- IMPA2 (IMPA2 Produkte)
- Hintergrund
-
Can use myo-inositol monophosphates, scylloinositol 1,4-diphosphate, glucose-1-phosphate, beta-glycerophosphate, and 2'-AMP as substrates.Has been implicated as the pharmacological target for lithium Li(+) action in brain.
- Molekulargewicht
- 31 kDa
- Gen-ID
- 3613
- NCBI Accession
- NM_014214, NP_055029
-